Yong Li

Person

Newark, DE, US

People

Patents Grantslast 30 patents

Information Patent Grant
CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination...
- Patent number 12,060,433
- Issue date Aug 13, 2024
- Incyte Corporation
- Horacio G. Nastri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused pyrazine derivatives as A2A / A2B inhibitors
- Patent number 11,999,740
- Issue date Jun 4, 2024
- Incyte Corporation
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused pyrazine derivatives as A2A / A2B inhibitors
- Patent number 11,161,850
- Issue date Nov 2, 2021
- Incyte Corporation
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS
- Publication number 20240360140
- Publication date Oct 31, 2024
- INCYTE CORPORATION
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPY COMPRISING AN FGFR INHIBITOR AND A KRAS INHIBITOR
- Publication number 20230226040
- Publication date Jul 20, 2023
- INCYTE CORPORATION
- Alejandro Amador Arjona
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS
- Publication number 20230056631
- Publication date Feb 23, 2023
- INCYTE CORPORATION
- Pei Gan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY COMPRISING A2A/A2B INHIBITORS, PD-1/PD-L1 INHIB...
- Publication number 20220233529
- Publication date Jul 28, 2022
- INCYTE CORPORATION
- Hui Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS
- Publication number 20220135570
- Publication date May 5, 2022
- INCYTE CORPORATION
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS
- Publication number 20210269434
- Publication date Sep 2, 2021
- INCYTE CORPORATION
- Xiaozhao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD73 INHIBITOR AND A2A/A2B ADENOSINE RECEPTOR INHIBITOR COMBINATION...
- Publication number 20210230294
- Publication date Jul 29, 2021
- INCYTE CORPORATION
- Horacio G. Nastri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination Therapy Comprising A2A/A2B and PD-1/PD-L1 Inhibitors
- Publication number 20210205311
- Publication date Jul 8, 2021
- INCYTE CORPORATION
- Hui Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS
- Publication number 20200031835
- Publication date Jan 30, 2020
- INCYTE CORPORATION
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination...

Fused pyrazine derivatives as A2A / A2B inhibitors

Fused pyrazine derivatives as A2A / A2B inhibitors

Patents Applicationslast 30 patents

FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS

COMBINATION THERAPY COMPRISING AN FGFR INHIBITOR AND A KRAS INHIBITOR

TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS

COMBINATION THERAPY COMPRISING A2A/A2B INHIBITORS, PD-1/PD-L1 INHIB...

FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS

TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS

CD73 INHIBITOR AND A2A/A2B ADENOSINE RECEPTOR INHIBITOR COMBINATION...

Combination Therapy Comprising A2A/A2B and PD-1/PD-L1 Inhibitors

FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS